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Curcumin Restores Corticosteroid Function in
Monocytes Exposed to Oxidants by Maintaining HDAC2
Koremu K. Meja1*, Saravanan Rajendrasozhan2*, David Adenuga2, Saibal K. Biswas2, Isaac K. Sundar2,
Gillian Spooner1, John A. Marwick1, Probir Chakravarty1, Danielle Fletcher1, Paul Whittaker1, Ian L. Megson3,
Paul A. Kirkham1‡, and Irfan Rahman2‡
1Novartis Institute for Biomedical Research, Respiratory Diseases, Horsham, United Kingdom; 2Department of Environmental Medicine, Lung
Biology and Disease Program, University of Rochester Medical Centre, Rochester, New York; and 3Free Radical Research Facility, UHI, Millennium
Institute, Inverness, United Kingdom
Oxidative stress as a result of cigarette smoking is an important
etiologic factor in the pathogenesis of chronic obstructive pulmonary
disease (COPD), a chronic steroid-insensitive inflammatory disease
of the airways. Histone deacetylase-2 (HDAC2), a critical component
of the corticosteroid anti-inflammatory action, is impaired in lungs of
patients with COPD and correlates with disease severity. We demon-
strate here that curcumin (diferuloylmethane), a dietary polyphenol,
at nanomolar concentrations specifically restores cigarette smoke
extract (CSE)- or oxidative stress–impaired HDAC2 activity and
corticosteroid efficacy in vitro with an EC50 of approximately 30 nM
and 200 nM, respectively. CSE caused a reduction in HDAC2 protein
expression that was restored by curcumin. This decrease in HDAC2
protein expressionwas reversed by curcumin even in the presence of
cycloheximide, a protein synthesis inhibitor. The proteasomal in-
hibitor, MG132, also blocked CSE-induced HDAC2 degradation, in-
creasing the levels of ubiquitinated HDAC2. Biochemical and gene
chip analysis indicated that curcumin at concentrations up to 1 mM
propagates its effect via antioxidant-independent mechanisms asso-
ciated with the phosphorylation-ubiquitin-proteasome pathway.
Thus curcumin acts at a post-translational level by maintaining both
HDAC2activity andexpression, thereby reversing steroid insensitivity
inducedbyeitherCSEoroxidative stress inmonocytes.Curcuminmay
therefore have potential to reverse steroid resistance, which is
common in patients with COPD and asthma.
Keywords: cigarette smoke; corticosteroid; macrophages; chronic
obstructive pulmonary disease; polyphenols
Oxidative stress is a central feature of many inflammatory
diseases and can be both an initiator and driving force of the
disease (1). The resulting tissue damage that occurs as a result
of oxidative stress can help drive an inflammatory response (2).
In chronic obstructive pulmonary disease (COPD), oxidative
stress due to cigarette smoke is considered to be the main
etiologic factor in disease pathogenesis (3, 4). The disease is
characterized by a chronic inflammatory response, leading to
a progressive and poorly reversible airflow limitation (5) that is
resistant to corticosteroid therapy (6, 7). The inflammatory
response is characterized by an influx of leukocytes into the
lung, in particular macrophages (8–10), as well as increases in
inflammatory mediators such as TNF-a and IL-8 (11). Bron-
choalveolar lavage (BAL) macrophages isolated from patients
with COPD also display resistance to corticosteroid-mediated
suppression of inflammation (12, 13). This apparent steroid
insensitivity can also be induced in U937 monocytes and A549
epithelial cells exposed to oxidative stress (14).
Corticosteroids are considered to be among the most effective
anti-inflammatories in clinical use at present. The suppression of
pro-inflammatory gene expression by the glucocorticosteroid
receptor (GR) has been shown to require the recruitment of
the transcriptional co-repressor HDAC2 into an activated GR
complex, referred to as transrepression (15–18). In contrast, the
anti-inflammatory activity of corticosteroids was not dependent
on GR-mediated gene expression through GR-DNA binding via
the glucocorticoid response element, otherwise known as trans-
activation (19). Subsequent in vivo studies by Reichardt and
coworkers (20) using the transgenic GRdim mouse supported this
hypothesis. HDAC2 is one of 18 isoforms within the HDAC
family (21, 22). A common feature of HDACs is the ability to
remove acetyl moieties from the e-acetoamido group on lysine
residues of acetylated proteins, such as histones (21). In general,
this results in condensation of the chromatin structure through
tighter winding of the DNA around the core histones. This
displaces the transcriptional machinery and occludes further
transcription factor binding, thereby resulting in gene silencing.
In contrast, histone acetylation by histone acetyltransferases
(HATs) disrupts the attractive electrostatic interaction between
the DNA and histones. This leads to the unwrapping of the DNA
from the core histones, allowing access for the transcriptional
machinery, resulting in gene transcription (23, 24). HDAC2 is
proposed to play a central role in gene repression by steroids
where the steroid receptor recruits HDAC2, which in turn
becomes associated into the NF-kB transcriptome complex,
thereby specifically shutting off pro-inflammatory gene expres-
sion (15, 25, 26). Oxidative stress inhibits HDAC2 activity (27,
28), and chronic oxidative stress, as seen in the lungs of patients
with COPD, caused both reduced HDAC2 activity and expres-
sion (29), thereby blocking steroid efficacy (14). Furthermore,
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inhibition of HDAC2 enhances pro-inflammatory gene expression
(27, 30) by tilting the HDAC/HAT balance in favor of greater
histone acetylation, opening up the chromatin structure to allow
more pro-inflammatory transcription factor DNA binding. Thus,
agents that restore HDAC2 may prove to be useful in restoring
steroid efficacy and hence inflammatory response.
Curcumin, a dietarypolyphenol, is the active constituent fromthe
Curcuma longa plant, commonly known as turmeric. It has been
reported to have both anti-cancer and anti-inflammatory properties
(31–33) and inhibits a wide range of inflammatory and signaling
molecules (34–38). Curcumin can also inhibit the formation of lipid-
derived inflammatory mediators, such as leukotrienes, through the
inhibition of PLA2,COX-2, and 5-LOXactivity in vitro (39).Due to
its polyphenolic structure, curcumin also exhibits antioxidant activ-
ity and is an effective scavenger of both reactive oxygen species
(ROS) and reactivenitrogen species (RNS) (40, 41).More recently,
curcumin has been demonstrated to induce antioxidant defenses
through increases in glutathione production (38), most likely as
a result of induction of Nrf2-mediated glutamate-cysteine ligase
transcription (42). Similarly, expressionof phase II enzymes suchas
glutathione-S-transferase is also induced by curcumin (43). At the
level of chromatin, two studies have shown that curcumin inhibits
HAT activity with no apparent impact on HDAC activity (44, 45).
However, neither study determined the impact of curcumin on
chromatin modifications in inflammatory cells subjected to oxi-
dative stress.Herewe investigatedwhether curcuminhadanyeffect
on HDAC2 in oxidatively stressed monocytes, and thus have the
potential to restore corticosteroid efficacy. Therefore, we studied
the mechanism of action of curcumin on HDAC2 due to its
antioxidant or free radical scavenging properties and/or post-
translational impact on prevention of phosphorylation-ubiquitina-
tion-proteosomal degradation of HDAC2.
MATERIALS AND METHODS
Reagents
Unless otherwise stated, all biochemical reagents used in this study
were purchased from Sigma Aldrich, Inc. (St. Louis, MO). Hydrogen
peroxide (H2O2), lipopolysaccharide (LPS), ionomycin, CGS 2180,
cycloheximide, dimethylsulfoxide (DMSO), protein A agarose, 3-(4,5-
dimethylthiazol-2-yr)-2-5-diphenyltetrazolium bromide (MTT), pyro-
gallol, xanthine, xanthine oxidase, menadione and Hanks’ Balanced
Salt Solution (HBSS) were purchased from Sigma Aldrich (Poole,
Dorset, UK). Research-grade cigarettes (Reference code 2R1/1R3F)
were obtained from the University of Kentucky (Lexington, KY).
Phorbol-12-myristate-13-acetate (PMA), CHAPS, and trichostatin A
(TSA), were purchased from Merck Biosciences (Boulevard Industrial
Park, Beeston, Nottingham, UK). Anti-HDAC1, anti–phospho-serine,
and anti-ubiquitin polyclonal antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal anti-acrolein
and anti-4-hydroxy-2-nonenal (4-HNE) (carbonyl) was prepared as
described previously (28, 49). Curcumin was purchased from Biomol
(Affiniti Research Products, Exeter, UK). The PDE4 inhibitor (roflu-
milast) was obtained from Qventas (Branford, CT) and the anti-
inflammatory corticosteroid (budesonide) from Sigma Aldrich. The
fluorometric HDAC activity assay kit was purchased from Biovision
(Mountain View, CA). MG-132, the proteasome inhibitor, was pur-
chased from Calbiochem (La Jolla, CA). TNF-a was obtained from
R&D Systems Europe (Abingdon, Oxfordshire, UK). Tempone-H-
HCl was sourced from Axxora Biochemicals (San Diego, CA). Micro-
array gene chips were purchased from Affymetrix (Santa Clara, CA).
Electron Paramagnetic Resonance Spectroscopic Assessment
of Antioxidant Properties
For these experiments, curcumin was made up at 100 mM in ethanol,
diluted to 1 mM in ethanol and further dilution to the desired working
concentration was made in HBSS. Xanthine was made up at 10 mM in
0.01 M NaOH, and menadione was made at 100 mM in DMSO. Both
compounds were subsequently diluted to a final concentration of 100 mM
in HBSS. Pyrogallol, xanthine oxidase, iron III (Fe31) chloride and
hydrogen peroxide were all dissolved and diluted in HBSS. Electron
paramagnetic resonance (EPR) measurements were made for a number
of different radical generating systems (pyrogallol, 100 mM; xanthine/
xanthine oxidase, 100 mM and 100 mU/ml; menadione, 50 mM; or iron
[III] chloride1 hydrogen peroxide, 50 mM1 10 mM, respectively) in the
presence of a well-recognized spin trap (tempone-H; 1 mM) and the
presence or absence of curcumin (1 nM–100 mM) after incubations at 1, 4,
and 24 hours (378C) using a benchtop EPR spectrometer (MS200 X-Band
Spectrometer; 9.30–9.55 GHz microwave frequency; Magnettech GmbH,
Berlin, Germany) set with the following parameters: B0 Field, 3,365
Gauss; sweep, 50 Gauss; sweep time, 30 s; modulation, 1,500 mG;
microwave power, 20 mW. Formation of the spin-adduct (4-oxo-tempo)
by oxidizing radical species generates a characteristic three-line spectrum
centered at approximately 3,365 Gauss, and the amplitude of the signal
(arbitrary units) is proportional to the concentration of the adduct formed.
Preparation of Aqueous Cigarette Smoke Extract
Research-grade cigarettes (1R3F) were obtained from the Kentucky
Tobacco Research and Development Center at the University of
Kentucky. The composition of 1R3F research-grade cigarettes was:
total particulate matter, 17.1 mg/cigarette; tar, 15 mg/cigarette; and
nicotine, 1.16 mg/cigarette. Cigarette smoke extract (CSE, 10%) was
prepared by bubbling smoke from one cigarette into 10 ml of culture
medium at a rate of one cigarette every 2 minutes as described
previously (46), using a modification of the method described earlier
by Carp and Janoff (47). CSE preparation was standardized by mea-
suring the absorbance (OD 0.766 0.05) at a wavelength of 320 nm. The
absorption spectrum observed at l320 showed very little variation
between different preparations of CSE. CSE was freshly prepared for
each experiment and diluted with culture medium.
Cell Culture and Treatments
The human monocytic cell line (U937) was obtained from the
American Type Culture Collection (ATCC, Rockville, MD) and
maintained in complete growth medium (RPMI 1640) supplemented
with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml
penicillin, and 100 mg/ml streptomycin at 378C in a humidified atmo-
sphere with 5% CO2. U937 were differentiated into an adherent
‘‘macrophage-like’’ morphology by exposure to PMA (40 ng/ml) for
4 hours in complete growth medium at 378C. Cells were harvested by
centrifugation (1,200 rpm, 4 min at 188C), resuspended in fresh com-
plete growth medium, and then subcultured into either in 96-, 12-, or
6-well culture plates (Corning, NY) at 0.23 106, 13 106, or 23 106/well,
respectively, and kept at 378C for a further 48 hours. The status of
differentiation or adherence was assessed under light microscopy. In
most cases, over 75% of the total population adhered to the surface
with a distinctive altered morphology (macrophage-like). Cell toxicity
was monitored by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide (MTT) assay. Cell viability was assessed by measuring LDH
release using cytotoxicity detection kit (Roche, Indianapolis, IN). After
differentiation, cells were starved overnight in phenol red–free RPMI
1640 medium with 0.5% FCS. The cells were then subjected to oxi-
dative stress for 4 hours using either H2O2 (100 mM) or CSE (1%) in
phenol red–free RPMI-1640 medium only. The medium was then
replaced and incubated with/without test compounds (curcumin 1 nM–
10 mM; trichostatin A 100 nM, cycloheximide 10 mg/ml). MG132 was
treated for 30 minutes and 4 hours before and after the oxidative insult,
respectively. For cell-based functional assays, the cells were subse-
quently treated with corticosteroid in the presence or absence of LPS
(10 ng/ml) for a further 18 hours. TNF-a and IL-8 release was
measured by sandwich enzyme-linked immunosorbent assay (R&D
Systems) in the culture supernatants. After compound treatment for up
to 18 hours, the cells were harvested and cellular protein or RNA
extracted as described below.
Cell Lysis, Immunoprecipitation, HDAC Activity Assay, and
Western Blotting
All details are as previously described (28). Briefly, cell protein extracts
were prepared using modified RIPA buffer (50 mM Tris HCL pH7.4,
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150 mM NaCl, 1% NP-40, 0.25% Na-deoxycholate, 1% CHAPS, 1 mM
EDTA with freshly added complete protease and phosphatase inhibitor
cocktail II (Calbiochem). Protein concentration was determined using
the Pierce BCA protein assay kit (Rockford, IL). Immunoprecipitation
was conducted with anti-HDAC1 (Santa Cruz Biotechnology, Santa
Cruz, CA) or anti-HDAC2 (Abcam, Cambridge, UK) antibodies.
HDAC activity on total cell lysates or immunoprecipitates was assessed
using a commercial fluorometric assay kit (Biovision, Mountain View,
CA). RIPA cell lysates or immunoprecipitates were subjected to western
blot after SDS-PAGE using mouse monoclonal anti-HDAC2 (Abcam).
Alternatively, to determine post-translational modifications of HDAC2,
blots were probed with either anti–phospho-serine, anti-acrolein,
anti24-HNE, or anti-ubiquitin antibodies. Blots were reprobed by
stripping with Chemicon Re-Blot Plus western recycling kit (Chemicon
International, Temecula, CA), blocked, and then reprobed with the
appropriate antibody.
Microarray Gene Chip Analysis
U937 differentiated cells, either untreated or ROS exposed as de-
scribed above, were treated with curcumin (1 mM) for either 4 or 18
hours. The cells were harvested and total RNA extracted using RNeasy
(Promega, Madison, WI). RNA integrity and yield were analyzed and
quantified using the Agilent Bioanalyser 2100 (Agilent Technologies,
Santa Clara, CA). Preparation of cDNA, hybridization, and scanning
of the HG-U133 Plus2.0 GeneChip oligonucleotide arrays were
performed according to the manufacturer’s protocol (Affymetrix,
Santa Clara, CA). GeneChip images were quantified and gene expres-
sion values were calculated by Affymetrix Microarray suite version 5.0
(MAS 5.0; Affymetrix). Normalization and downstream analysis was
performed using Genespring 7.2 (Agilent Technologies). Probesets
that were absent and/or had a raw expression signal less than 100 in all
samples were removed. Statistically significant genes were identified
Figure 1. Curcumin restores reactive oxygen spe-
cies (ROS)- and cigarette smoke extract (CSE)-
impaired corticosteroid efficacy by inhibiting the
pro-inflammatory cytokines in human monocytes.
Phorbol-12-myristate-13-acetate (PMA)-differenti-
ated U937 cells were stressed for 4 hours with CSE
(1%), then left for a further 18 hours (A, C, and E ), or
with H2O2 (100 mM) followed by LPS (10 ng/ml) for
18 hours (B, D, F, and G). Immediately after ROS and
CSE exposures, the cells were treated with increasing
concentrations of curcumin alone (E and F ) or in
combination with corticosteroid; dexamethasone,
100 nM (C ) or budesonide, 1 nM (D and G). As
internal controls for C and D, dotted horizontal lines
represent cytokine levels in naı¨ve cells or LPS-treated
naı¨ve cells in the presence of budesonide (1 nM),
respectively. ROS-stressed cells were also treated
with a curcumin-budesonide combination in the
presence of trichostatin A (TSA), 100 nM (G). TNF-a
and IL-8 release was evaluated by enzyme-linked
immunosorbent assay as described in MATERIALS AND
METHODS. The data are displayed as the mean6 SEM
of at least three independent experiments, except
for G, where the data represent the mean6 SEM for
duplicate experiments. Where indicated the data
is normalized against control; cells stimulated with
CSE only (C and E ) or cells treated with LPS only (D, F,
andG). *P, 0.05, ***P, 0.001 versus control using
ANOVA with Bonferroni post hoc analysis. Vehicle,
DMSO.
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using a 1.8-fold change cutoff and a P value of , 0.05 (Welch’s t test,
parametric with variances assumed not equal). Differentially expressed
genes from naı¨ve versus ROS (H2O2, 100 mM)-exposed cells with/
without subsequent curcumin treatment were used to generate hierar-
chical clustering plots using Pearson’s correlation and displayed as
heatmaps. Gene chip data have been deposited with the GEO database
at the NCBI with accession number GSE10896.
Data and Statistical Analysis
Data points were plotted as the mean 6 SEM of ‘‘n’’ independent
experiments. Concentration–response curves were analyzed by least
square non linear regression using ‘‘Prism’’ curve fitting software (Graph
Pad, San Diego, CA). Statistical analysis was conducted using one- or
two-way ANOVA with Dunnett’s or Bonferroni post hoc analysis, as
appropriate. For the gene chip arrays, Welsh t test was employed to
determine significance. P , 0.05 was considered significant.
RESULTS
Curcumin Restores CSE- and Oxidant-Induced
Steroid Insensitivity
We determined the anti-inflammatory efficacy of corticosteroids
on the pro-inflammatory effects of exposure to CSE and
a potent oxidant hydrogen peroxide (H2O2) in monocytic cells
(human monocytic cell line, U937). Exposure of U937 cells to
either CSE or H2O2 resulted in an inability of corticosteroid to
suppress the ensuing pro-inflammatory response (Figures 1A
and 1B). CSE (1%) exposure caused a significant (P , 0.01)
increase in IL-8 release from U937 cells (Figure 1A). Sub-
sequent treatment of the CSE exposed cells for 18 hours with
dexamethasone failed to suppress the IL-8 release. In contrast,
when U937 cells were exposed to LPS alone, the corticosteroid
budesonide was able to significantly inhibit pro-inflammatory
mediator release as measured by TNF-a (Figure 1B). However,
pre-exposure of the differentiated U937 cells to oxidative stress
in the form of H2O2 before LPS treatment led to an inability of
budesonide to suppress LPS induced TNF-a release to levels
observed with budesonide on LPS treatment alone (Figure 1B).
Interestingly, H2O2 treatment alone did not have much effect
on TNF-a release and moreover, when H2O2 was used in
conjunction with LPS there was a small enhancement in TNF-
a release over that for LPS stimulation alone (data not shown).
All these treatments did not show any significant cytotoxic
effect as measured by LDH release and MTT assay.
We next investigated whether curcumin could potentiate or
restore the impaired anti-inflammatory efficacy of corticoste-
roid in cells exposed to oxidative stress. U937 cells were pre-
exposed to CSE, and then treated with increasing concentra-
tions of curcumin, either in the presence (Figure 1C) or absence
(Figure 1E) of corticosteroid (dexamethasone). Alternatively,
U937 cells were pre-exposed to H2O2, then treated with various
concentration of curcumin in the presence (Figure 1D) or
absence (Figure 1F) of corticosteroid (budesonide) followed
by LPS (10 ng/ml) stimulation for 18 h (Figures 1D and 1F). In
both the CSE and H2O2 exposure systems, curcumin showed
a concentration-dependent restoration of corticosteroid-medi-
ated suppression of pro-inflammatory cytokine release with an
EC50 of between 200 and 300 nM (Figures 1C and 1D). In the
case of the CSE system (Figure 1C), the ability of corticosteroid
in the presence of curcumin to suppress the inflammatory IL-8
response was virtually complete, with the resulting IL-8 levels
similar to that for unstimulated cells. Similarly, in the H2O2–
LPS system, curcumin again restored the ability of corticoste-
roid to suppress the LPS-induced TNF-a release to levels
observed in naı¨ve unstressed cells (dotted horizontal line in
Figure 1D). In contrast, in both ROS exposure systems (CSE
and H2O2), curcumin in the absence of corticosteroid did not
show a significant concentration-dependent inhibition in pro-
inflammatory mediator release (Figures 1E and 1F). However,
in the case of CSE (Figure 1E) there is clearly an overall anti-
inflammatory shift throughout the concentration range studied
relative to CSE alone (100% control). In Figure 1G, addition
of trichostatin A, a specific and potent HDAC inhibitor, com-
pletely removed the concentration-dependent restoration of
corticosteroid efficacy by curcumin observed in Figure 1D.
Coupled with the impact curcumin has on restoring HDAC2
activity (Figure 2), this was suggestive that restoration of
corticosteroid efficacy by curcumin was indeed HDAC2 de-
pendent. We also used another human non–PMA-stimulated
macrophage cell line, MonoMac6 (49), to confirm the results,
which also shown similar response as described for U937 cells
(data not shown).
Effect of Curcumin on Total and Isoform-Specific
HDAC Activity
Treatment of CSE- or H2O2-stressed U937 cells with curcumin
resulted in a restoration of total HDAC activity compared with
un-stressed cells alone (Figure 2A). Initially, exposure to either
CSE (1%) or H2O2 (100 mM) for 4 hours, significantly (P ,
0.01) reduced total HDAC activity by 40% relative to untreated
cells (Figure 2A), whereas CSE or H2O2 exposure did not show
Figure 2. Curcumin restores ROS-impaired histone deacetylase
(HDAC)2 in human monocytes. (A) ROS- and CSE-stressed (100 mM
H2O2 or 1% CSE for 4 h) U937 were treated with and without curcumin
(1 mM) for 18 hours at 378C before measuring total cellular HDAC
activity. (B) Isoform-specific HDAC activity was assessed in immuno-
precipitates of HDAC1 (open bars) and HDAC2 (solid bars) from lysates
of U937 cells that had been pre-exposed to H2O2 (100 mM) for 4 hours,
followed by treatment with curcumin as indicated. HDAC activity is
displayed as the mean 6 SEM of at least three independent experi-
ments and normalized against control (naı¨ve untreated cells). The PDE4
inhibitor (roflumilast) was used in parallel as a negative control to
validate the action of curcumin and was unable to restore HDAC2
activity. ***P , 0.001 versus control. #P , 0.05, ##P , 0.01 versus
H2O2-/CSE-stressed cells only.
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any significant change in cytotoxicity as measured by LDH
release (data not shown). As a positive control, the HDAC
inhibitor TSA inhibited total HDAC activity by as much as
85%. However, when either the CSE or H2O2 exposed cells
were then treated with curcumin (1 mM), there was a significant
increase in total HDAC activity returning back to pre-oxidant
exposure levels (Figure 2A). The impact of curcumin on HDAC
activity was unique to CSE- or H2O2-exposed cells, as naı¨ve
cells treated with curcumin had no impact on HDAC activity
(data not shown).
AsHDAC2has been shown to be an essential co-factor for the
anti-inflammatory efficacy of corticosteroids, we investigated the
impact of curcumin on HDAC2 activity and a close isoform of
HDAC2, namely HDAC1, which contains 83% identity (21).
Total cellular lysates derived from curcumin-treated U937 cells
with/without pre-oxidant stress were subjected to immunopre-
cipitation with anti-HDAC1 or anti-HDAC2 polyclonal anti-
bodies. The resulting immunoprecipitates were then used for the
measurement of isoform-specific HDAC activity as described
earlier in MATERIALS AND METHODS. The results displayed in
Figure 3. Evaluation of the antioxidant/radical quenching
properties of curcumin by electron spin resonance spectros-
copy. Curcumin at various concentrations (1 nM to 100 mM)
was mixed with four different free radical electron–generating
systems: (A) pyrogallol, (B) xanthine/xanthine oxidase, (C )
menadione, and (D) H2O2/FeCl3. The antioxidant/radical
quenching capacity was evaluated by measuring the electron
paramagnetic resonance (EPR) signals (arbitrary units, AU)
due to oxidation of Tempone-H (1 mM). Decreased EPR
signals show increased antioxidant capacity and vice versa.
The data shown is the mean 6 SEM for six experiments. *P ,
0.05, ***P , 0.001 versus control. Curcumin concentrations
are shown with the following symbols: solid diamonds, 100
mM; open squares, 10 mM; solid squares, 1 mM; open triangles,
100 nM; solid triangles, 10 nM; open circles; 1 nM; solid circles,
no curcumin.
TABLE 1. EARLY PHASE (4 h) CURCUMIN-REGULATED GENES WITH KNOWN FUNCTION
Accession Number Gene Name Biological Function Cell Status
Expression
Status
AI217992 Pleckstrin homology domain containing, family H member 2 Cell adhesion Naı¨ve [
AI770005 Polycystic kidney and hepatic disease 1 (autosomal recessive) Cell adhesion Naı¨ve [
W72626 Boc homolog (mouse) Cell adhesion ROS [
S78505 Prolactin receptor Cell signaling Naı¨ve [
AV700865 SET-binding factor 2 Cell signaling Naı¨ve [
AW974499 Rho GTPase–activating protein 30 Cell signaling Naı¨ve Y
BE673800 Family with sequence similarity 80, member A Cell signaling ROS [
AL512701 Protein kinase C, eta Cell signaling ROS [
AK021928 RAB3 GTPase activating protein subunit 2 (noncatalytic) Cell signaling ROS Y
BC040296 Exocyst complex component 4 Intacellular transport Naı¨ve [
BC042091 Sec1 family domain containing 2 Intacellular transport Naı¨ve Y
NM_003759 Solute carrier family 4, sodium bicarbonate cotransporter, member 4 Intacellular transport ROS [
BE818251 ATPase, Class II, type 9B Intacellular transport ROS Y
BG222394 Mitogen-activated protein kinase 8 interacting protein 1 Intacellular transport ROS Y
BC015196 Geranylgeranyl diphosphate synthase 1 Metabolic pathways Naı¨ve [
AW390231 Hypothetical protein KIAA1434 Metabolic pathways Naı¨ve [
BC011938 TGFB1-induced anti-apoptotic factor 1 Metabolic pathways Naı¨ve [
NM_004795 Klotho Metabolic pathways ROS [
AW022496 Zinc finger, A20 domain containing 1 Protein degradation Naı¨ve Y
AI742722 Ubiquitin-conjugating enzyme E2E 1 (UBC4/5 homolog, yeast) Protein degradation ROS Y
AK093340 STAM-binding protein-like 1 Protein degradation ROS Y
BC017989 Similar to ribosomal protein L31 Gene regulation Naı¨ve [
NM_002147 Homeobox B5 Gene regulation Naı¨ve [
AK024514 Suppressor of zeste 12 homolog (Drosophila) Gene regulation Naı¨ve Y
AF007135 Jumonji, AT rich interactive domain 1A (RBBP2-like) Gene regulation ROS Y
NM_014258 Synaptonemal complex protein 2 Cell cycle/Apoptosis Naı¨ve [
AK024940 Tumor necrosis factor, alpha-induced protein 8 Cell cycle/Apoptosis Naı¨ve [
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Figure 2B show that ROS (hydrogen peroxide) exposure had no
significant impact on HDAC1 activity. In contrast, ROS abol-
ished HDAC2 activity by almost 90% compared with that in
normal naı¨ve cells. Treatment with increasing concentrations of
curcumin restored HDAC2 activity back to normal levels found
in naı¨ve cells in a concentration-dependent manner, with an
approximate EC50 of 30 nM. The PDE4 inhibitor (roflumilast)
was used in parallel as a negative control to validate the action of
curcumin and was unable to restore HDAC2 activity. As a pos-
itive control, U937 cells that had been treated with trichostatin A
displayedvery little or nodeacetylase activity in both theHDAC1
and HDAC2 isoforms tested. Similar responses were also ob-
served in MonoMac6 cells exposed to CSE (data not shown).
Antioxidant Properties of Curcumin in Free
Radical–Generating Systems
Curcumin is a polyphenol with known antioxidant properties at
high concentrations (32). In view of the observation that ROS
exposure reduced HDAC2 activity and nanomolar concentra-
tions of curcumin were able to restore HDAC2 activity and
corticosteroid efficacy with approximate EC50 of 30 nM and
200 nM, respectively, we investigated whether or not curcumin
could still act as an antioxidant at nanomolar concentrations. To
assess the pharmacologic nature of curcumin’s antioxidant prop-
erties, a dose–response effect for curcumin in several different
free radical– or oxidant-generating systems was determined
(Figure 3). EPR spectroscopy was used to evaluate the antioxi-
dant free radical–scavenging potential of curcumin. Below 1 mM,
curcumin did not possess any significant free radical–scavenging
activity in the four systems studied here. However, at 10 mM,
curcumin did show some weak antioxidant capacity in the
xanthine/xanthine oxidase free radical–generating system. By
100 mM the antioxidant capacity of curcumin is clearly evident,
as observed by a significant reduction in the EPR signal at the
24-hour time point in all four free radical–generating systems
studied (Figure 3). Therefore, at concentrations less than 10 mM,
TABLE 2. LATE PHASE (18 h) CURCUMIN-REGULATED GENES WITH KNOWN FUNCTION
Accession Number Gene Name Biological Function Cell Status Expression Status
BC035328 Microsomal glutathione S-transferase 2 Antioxidant/Detoxification ROS [
AF130082 Collagen, type III, alpha 1 Structural proteins Naı¨ve Y
AK057448 Syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) Muscle contraction Naı¨ve Y
BF057731 Major histocompatibility complex, class II, DP beta 2 (pseudogene) Inflammation/immunity Naı¨ve Y
AF315688 Interferon, kappa Inflammation/immunity Naı¨ve Y
AA779991 Calcium binding atopy-related autoantigen 1 Inflammation/immunity ROS [
AW301806 ADP-ribosylation factor-like 6 interacting protein 2 Inflammation/immunity ROS Y
BF508564 Ectonucleoside triphosphate diphosphohydrolase 1 Cell adhesion Naı¨ve Y
AA053711 EGF-like repeats and discoidin I–like domains 3 Cell adhesion Naı¨ve Y
BE219446 Muscle RAS oncogene homolog Cell signaling Naı¨ve [
AI862674 Membrane-spanning 4-domains, subfamily A, member 1 Cell signaling Naı¨ve [
NM_004274 A kinase (PRKA) anchor protein 6 Cell signaling Naı¨ve [
AU147360 Protein tyrosine phosphatase, receptor type, A Cell signaling ROS [
AK091846 Hypothetical protein MGC35295 Cell signaling ROS Y
AI590659 AlkB, alkylation repair homolog 8 (Escherichia coli) Cell signaling ROS Y
NM_002314 LIM domain kinase 1 Cell signaling ROS Y
NM_021094 Solute carrier organic anion transporter family, member 1A2 Intacellular transport Naı¨ve [
AL050263 Solute carrier family 1 (glial high-affinity glutamate transporter), member 3 Intacellular transport Naı¨ve [
AA960991 Sideroflexin 1 Intacellular transport Naı¨ve Y
AF085911 Solute carrier family 5 (sodium/glucose cotransporter), member 11 Intacellular transport Naı¨ve Y
AK024543 Neuron navigator 1 Intacellular transport Naı¨ve Y
BF446577 Mitochondrial carrier triple repeat 6 Intacellular transport ROS [
AI718937 Potassium channel tetramerisation domain containing 12 Intacellular transport ROS Y
AI963713 Enabled homolog (Drosophila) Intacellular transport ROS Y
BC000879 Kynureninase (L-kynurenine hydrolase) Metabolic pathways Naı¨ve [
AW297143 HBS1-like (Saccharomyces cerevisiae) Metabolic pathways Naı¨ve Y
W72516 Dihydropyrimidinase-like 3 Metabolic pathways ROS [
BF692729 Exosome component 6 Metabolic pathways ROS Y
AI190575 Farnesyl pyrophosphate synthetase like Metabolic pathways ROS Y
AW510697 Ubiquitin C Protein degradation Naı¨ve Y
NM_005133 RCE1 homolog, prenyl protein peptidase (S. cerevisiae) Protein degradation ROS [
AI309207 Membrane-associated ring finger (C3HC4) 7 Protein degradation ROS Y
AL359578 Zinc finger protein 287 Gene regulation Naı¨ve [
BC028160 Zinc finger protein 589 Gene regulation Naı¨ve Y
BF665176 KRR1, small subunit (SSU) processome component, homolog (yeast) Gene regulation Naı¨ve Y
R44780 Ets variant gene 1 Gene regulation Naı¨ve Y
AF265440 Mitochondrial translational initiation factor 3 Gene regulation ROS [
BC001800 Orthopedia homolog (Drosophila) Gene regulation ROS [
AW149379 Ribosomal protein L41 Gene regulation ROS [
BF241405 Exosome component 3 Gene regulation ROS Y
AI248610 Forkhead box P1 Gene regulation ROS Y
BC029395 M-phase phosphoprotein 6 Cell cycle/Apoptosis Naı¨ve Y
AI057404 Cyclin I Cell cycle/Apoptosis ROS Y
NM_013347 Replication protein A4, 34kDa Cell cycle/Apoptosis ROS Y
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curcumin was unable to act as an antioxidant in the four systems
studied, which would imply that the impact of curcumin at
nanomolar concentrations on HDAC2 activity observed here
was unlikely tobedue toanydirect antioxidant effects, as ourdata
show.
Impact of Curcumin on Gene Expression
Given that curcumin (1 mM) was able to induce maximal effects
on restoration of both HDAC activity and corticosteroid
responses, we investigated what impact a similar concentration
of curcumin would have on differentiated U937 cell gene
expression. Of particular interest were those genes involved in
inflammation, antioxidant protection, and HDAC, especially
when differentiated U937 cells had been pre-exposed to ROS
(H2O2). Differentiated U937 cells, with or without ROS stress,
were cultured with 1 mM curcumin for up to 18 hours. Total
RNA extracted from two distinct time points, 4 and 18 hours
after curcumin addition, was probed on Affymetrix HG-U133
plus2.0 gene chips. Microarray gene expression data was
collected from three independent experiments and analyzed
using Genespring software (Agilent technologies). A cutoff
threshold of greater than 1.8-fold change in expression was
chosen. Only those genes that significantly met this threshold as
defined by Welsh’s t test (P , 0.05) are listed in Tables 1 and 2
and graphically displayed as a heatmap in Figure 4. A compar-
ison of naı¨ve versus ROS-stressed cells indicated that 4 hours
after ROS stress a total of 298 genes are significantly affected,
and that this drops to 71 genes 18 hours after ROS stress.
Curcumin can be seen to affect both normal and ROS-stressed
U937 cells at both 4- and 18-hour time points. After 4 hours,
there were 77 curcumin-responsive genes that significantly
changed in curcumin-treated U937 cells. Only 40 of these genes
code for proteins with known function (Table 1). By 18 hours,
a different set of curcumin-responsive genes had undergone
significant changes in expression, and the number of genes had
increased to 98, of which 44 were genes with known function
(Table 2). Analysis of both these gene lists (Tables 1 and 2)
revealed that curcumin (1 mM) did not induce any known
antioxidant response genes in our experiments. Moreover, as
curcumin is reported to activate the antioxidant transcription
factor NF-E2–related factor (Nrf-2), no Nrf-2 responsive genes
as identified by Thimmulappa and colleagues (48) were evident
among those inducible genes seen here using this low concen-
tration and earlier time points of curcumin treatments (Tables 1
and 2). Similarly, 1 mM curcumin had no widespread impact
in down-regulating any pro-inflammatory genes induced by
ROS. With respect to HDAC gene expression, no changes
Figure 4. Effect of curcumin of gene expression in response to ROS stress. Heatmap showing hierarchical clustering of differentially expressed genes
between naı¨ve versus ROS-stressed human monocytes after curcumin (1 mM) treatment for (A) 4 and (B) 18 hours. Condition clustering (vertical)
shows the average of three independent samples. Only genes with a statistically significant change greater than 1.8-fold, as defined by Welsh’s t test
(P , 0.05), are shown. Red indicates increased gene expression, green decreased expression, and black no change.
Figure 5. Gene expression profile show-
ing the impact of curcumin (1 mM) on dif-
ferent HDAC isoforms in naı¨ve and ROS-
stressed human monocytes. Only those
HDAC isoforms shown to be significantly
expressed as detected by microarray anal-
ysis from three independent samples
are shown. (A) Four hours after ROS, (B)
18 hours after ROS exposure. Hatched
bars, control; cross-hatched bars, curcu-
min (1 mM); open bars, H2O2 (100 mM);
solid bars, curcumin 1 H2O2.
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in gene expression were evident among any of the HDAC
genes detected. Indeed, 4 hours of ROS-mediated stress had
very little impact on HDAC gene expression. The added impact
of curcumin exposure again did not significantly change HDAC
gene expression (Figure 5). These data suggest that curcumin
mediated restoration of HDAC2 activity and that corticosteroid
efficacy was not due to HDAC2 gene induction or pro-
inflammatory gene suppression via NF-kB–dependent mecha-
nisms per se. Interestingly, genes associated with protein
degradation through the ubiquitin cycle at both the 4- and 18-
hour time points (such as the zinc finger–A20 domain contain-
ing protein, ubiquitin-conjugating enzyme E2E, STAM-binding
protein, and ubiquitin C protein) were significantly down-
regulated by curcumin (Tables 1 and 2).
Curcumin Retains Post-Translational Protein Expression of
HDAC2 after ROS Stress
Previously, we have shown that HDAC2 is modified at the post-
translational level in response to oxidative stress (28, 49). To
determine any post-translational impact of curcumin on HDAC
expression, Western blots against HDAC2 were conducted.
Figure 6A demonstrates that CSE exposure caused a reduction
in HDAC2 protein expression, compared with H2O2 exposure
(Figure 6B). As such, subsequent experiments (Figure 7) in-
vestigated whether curcumin in both the presence (Figure 7B)
and absence (Figure 7A) of cycloheximide had any impact on
HDAC2 protein expression. When U937 cells were also ex-
posed to the protein synthesis/translation inhibitor cylcohex-
imide for 4 hours, there was a noticeable loss in HDAC2 protein
expression, suggestive that there is a rapid turnover of HDAC2
(Figure 7B). Again, CSE is seen to reduce HDAC2 protein
levels which when followed with cycloheximide for 4 hours after
CSE stress, resulted in further loss of HDAC2 protein levels.
However, when curcumin was incubated in the presence of
cycloheximide for 4 hours after CSE stress, there was a concen-
tration-dependent restoration in HDAC2 levels from those seen
with CSE stress and cycloheximide to levels seen with cyclo-
heximide alone. As cycloheximide is known to block the
de novo synthesis of new protein, in this case HDAC2; this
leads one to summarize that curcumin may block the degrada-
tion of existing HDAC2 protein induced by CSE. Moreover, the
concentration range over which curcumin apparently blocks this
HDAC2 degradation is similar to the range in which it restores
HDAC2 activity and corticosteroid function. This prevention of
CSE-induced reduction in HDAC2 protein expression by curcu-
min, could also be mimicked by the proteasomal inhibitor
MG132 (Figure 8A). Indeed, the CSE-induced increase in
ubiquitinated HDAC2 was increased even further by MG132
(Figure 8B). Interestingly, MG132 alone on naı¨ve cells also
induced an increase in ubiquitinated HDAC2 (Figure 8B), which
suggests that HDAC2 itself may have a high turnover. In Figure
8C, we also show that CSE induced serine phosphorylation of
HDAC2 and curcumin reversed this phosphorylation in U937
cells. This would indicate that HDAC2 undergoes a classical
pathway of phosphorylation-ubiquitination-degradation upon
exposure to CSE.
In view of reactive oxidants and reactive aldehydes present
in cigarette smoke, we investigated the effect of curcumin on
covalently modified HDAC2 by acrolein and 4-HNE, the
reactive aldehydes that are present in cigarette smoke and
formed as a result of lipid peroxidation. Covalent modification
of HDAC2 protein was assessed by immunoprecipitation,
followed by Western blot analysis using anti-acrolein or anti–
4-HNE antibody. There was a significant increase in carbonyl-
ation of HDAC2 (HDAC2-acrolein and HDAC2–4-HNE in-
teraction) in oxidant-treated differentiated U937 cells, which
was significantly reduced by curcumin treatment (Figure 8D). A
similar response was also observed in CSE-treated MonoMac6
cells (data not shown). This would support the concept that
curcumin protects the cells from reactive oxidant/aldehyde-
mediated post-translational modifications.
DISCUSSION
Glucocorticoid resistance is known to occur in COPD and
severe asthma due to increased oxidative stress. It has been
shown that corticosteroids recruit HDAC2 to the promoter of
pro-inflammatory genes, thereby suppressing pro-inflammatory
gene transcription (15, 18, 19, 50). Oxidative stress induced by
CSE and H2O2 reduced both HDAC2 activity and corticoste-
roid efficacy in monocytes. No effect of oxidative stress was
observed on HDAC1. Curcumin restored both HDAC2 activity
and corticosteroid efficacy, in a concentration-dependent man-
ner, with an EC50 of around 30 nM and 200 nM, respectively.
Figure 6. CSE, but not H2O2, decreases HDAC2 levels
in human monocytes. (A) U937 cells were exposed to
CSE (1%) for 4 hours and the HDAC2 levels were
assessed by Western blot. (B) U937 cells were exposed
to H2O2 (100 mM) and then analyzed for HDAC2 by
Western blot immediately after ROS exposure (4 h)
and 4 hours after ROS exposure (8 h). As internal
loading controls, blots were stripped and reprobed for
either GAPDH or lamin B protein levels. The blots
shown are representative of the experiment being
repeated at least three times (n 5 3). ***P , 0.001,
significant compared with control.
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Restoration of ROS-impaired corticosteroid function by curcu-
min was also shown to be HDAC dependent, as a global HDAC
inhibitor, TSA, abolished the effect of curcumin. The impact of
curcumin, at concentrations less than 1 mM, on HDAC activity
and corticosteroid function in pre–oxidant-stressed cells could
not be attributed to either the inherent antioxidant properties
of curcumin, or the indirect antioxidant effects through gene
induction. Indeed, both the direct and indirect antioxidant
effects are reported to occur at curcumin concentrations greater
than 10 mM (38, 42). These concentrations are at least 100- to
1,000-fold higher than the observed effects on HDAC activity
reported here. However, we did observe that CSE caused
a reduction in HDAC2 protein levels. Moreover, curcumin
was able to reverse this decline in HDAC2 protein expression,
even in the presence of the de novo protein synthesis inhibitor
cycloheximide, suggesting that curcumin inhibited the CSE-
induced degradation of HDAC2.
Theophylline, a compound structurally unrelated to curcu-
min, can also induce HDAC activity and restore corticosteroid
efficacy in BAL macrophages from patients with COPD (13).
However, theophylline has a narrow window of efficacy on
HDAC2 and thus is not the drug of choice for use in the
treatment of steroid-resistant COPD. It has been postulated
that a major anti-inflammatory role of corticosteroids is to
recruit HDAC2 activity to the promoter sites of pro-inflamma-
tory gene expression (15, 18, 19, 50). This results in localized
chromatin deacetylation and condensation, thereby silencing
pro-inflammatory gene expression at these sites (15). The
identification of curcumin’s ability to restore HDAC activity
and corticosteroid efficacy, similar to that of theophylline, raises
interesting questions as to the mechanism by which both
compounds are able to achieve this. Ito and coworkers (15)
demonstrated that incubating theophylline with immunopreci-
pitates of HDAC2 did not have a direct impact in elevating
HDAC activity (15). Similarly, we have also observed that
curcumin did not have any direct impact on deacetylase activity
in immunoprecipitates of HDAC2 from ROS-stressed mono-
cytes (P. A. Kirkham and colleagues, unpublished observa-
tions). However, as curcumin did restore HDAC2 activity in
intact ROS-stressed cells, this would imply an indirect effect of
Figure 7. Curcumin restored HDAC2 protein
level in response to CSE exposure, which was
not masked by cycloheximide treatment. (A)
U937 cells exposed to CSE (1%) for 4 hours
were then treated with various concentrations
of curcumin for a further 4 hours in the absence
(A) or presence (B) of cycloheximide (10 mg/ml).
HDAC2 levels were assessed by Western blot in
the nuclear fraction. Actin was assessed as a load-
ing control. The results shown are representative
of the experiment being repeated at least three
times (n 5 3). ***P , 0.001, significant com-
pared with untreated cells; ##P , 0.01, ###P ,
0.001, significant compared with CSE- or
CSE1cycloheximide-treated group.
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curcumin in regulating HDAC2 activity. Interestingly, curcumin
did not have any impact on HDAC2 activity in naı¨ve ‘‘non–
ROS-stressed’’ monocytes. This latter finding is in agreement
with that of Kang and coworkers, who found that curcumin at
concentrations up to 100 mM had no impact on HDAC activity
in hepatic Hep3B cells (45). This would suggest that under basal
conditions HDAC2 remains constitutively active and that it is
only under certain conditions, such as ROS stress, in which
HDAC activity is reduced, that curcumin is able to restore
HDAC activity back to basal levels. By maintaining HDAC
activity in such a high state, it would not only keep a check
on unnecessary pro-inflammatory gene expression (30), but
would also allow the cells to respond rapidly to external stimuli
by recruiting HDAC activity as appropriate to where it is
needed. Nevertheless, regulation of HDAC activity can be
accomplished in several ways, none of which are mutually
exclusive; through post-translational modification, protein–
protein interaction, subcellular localization, and protein expres-
sion status (51).
We and others have recently shown that oxidative stress, both
in vitro and in vivo, can cause changes in post-translational
modification of HDAC2, such as tyrosine nitration, carbonyla-
tion, and phosphorylation (27, 28, 49). Moreover, while these
modifications have been demonstrated by us to affect activity (28,
49), they have also been shown to tag proteins for ubiquitination
and eventual degradation (52). Our results here would suggest
that curcumin does not impact on HDAC2 gene expression, but
restores HDAC2 activity through regulation of its protein
expression status, by preventing CSE-induced degradation of
HDAC2. Moreover, our gene expression data lend additional
support to this conclusion, as curcuminwas seen to down-regulate
gene expression for proteins associated with protein degradation,
such as the zinc finger-A20domain–containing protein, ubiquitin-
conjugating enzyme E2E, STAM-binding protein, and the ubiq-
uitinCprotein (Tables 1 and 2).Equally plausible, however, is the
possibility that curcumin acts earlier by preventing or even
reversing any post-translational modifications that tag HDAC2
for eventual degradation through the ubiquitination pathway.
The impact of CSE on reducing HDAC2 protein expression, as
shown here, was clearly greater than that achieved with H2O2,
even though both CSE and H2O2 caused a reduction in HDAC
activity and corticosteroid efficacy. This may simply reflect the
possibility that CSE, unlike H2O2, is a heterogenous mixture of
chemicals containingbothROSand reactive aldehydes/carbonyls
and therefore more likely to have a greater impact on the type of
post-translational modifications (carbonyl-adducts formation)
that can arise on any exposed proteins. This in turn could make
any extensively modified proteins more susceptible to ubiquiti-
nation and eventual degradation by 26S proteasomes. Indeed, we
observed that exposure of monocytes to CSE resulted in in-
creasedHDAC2ubiquitination.Alternatively, post-translational
modifications can also affect protein–protein interactions, in
particular the co-repressors SDS3, Mi2, Sin3A, NCoR, and
CoREST, which are essential for HDAC activity (53, 54), the
disruption of which would have a detrimental effect on HDAC
activity (55). What is clear, however, is that curcumin clearly acts
at a post-translational level by reducing the level of protein
carbonylation and serine phosphorylation on HDAC2, as well as
restoring its activity.
Curcumin at high concentrations (z 100 mM) has been shown
to inhibit IkB kinase (56, 57), blocking NF-kB activation (34, 58)
and subsequent IL-8 expression in A549 cells by pro-inflamma-
tory stimuli such as TNF-a and ROS (38). Recently, Sandur and
colleagues (59) reported that curcuminmediates its apoptotic and
Figure 8. CSE-induced reduc-





tiated U937 cells were treated
with either MG132 (1 mM)
alone, exposed to CSE (1%)
alone, or both together for 4
hours, then treatedwithorwith-
out MG132 (1 mM) alone for
a further 4 hours as indicated.
Cell lysates were probed for
HDAC2 by Western blot using
lamin B as an internal nuclear
loading control (A). Alterna-
tively, immunoprecipitates of
HDAC2 were probed by West-
ern blot for ubiquitin content
using an HDAC2 Western blot
as an internal loading control (B)
or serine phosphorylation (C).
The level of HDAC2-carbonyl
adduct (acrolein or 4-HNE) was
increased in response to CSE
treatment, which was attenu-
ated by curcumin (1 mM) treat-
ment (D). The blots shown are
representativeof theexperiment
being repeated at least three
times (n 5 3). *P, 0.05, **P,
0.01, ***P , 0.001, significant
compared with control value.
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anti-inflammatory activities through modulation of the redox
status of the cell at mM concentrations. However, in ROS-
stressed monocytes, curcumin alone (up to 10 mM) did not show
any anti-inflammatory effect toward LPS-induced TNF-a re-
lease. Moreover, curcumin did not display any significant dose-
dependent anti-inflammatory effects against ROS-induced pro-
inflammatory cytokine release in the face of CSE alone. This
suggests that restoring HDAC alone is not anti-inflammatory
unless it is recruited to the site of pro-inflammatory gene
expression. Similar observations have also been described for
theophylline in U937 cells (13). The discrepancy between the
impact of curcumin at low and high concentration on ROS-
induced inflammation may be due to two factors: the intrinsic
antioxidant properties of curcumin at high concentrations, and
the ability to induce antioxidant as well as suppress pro-in-
flammatory gene expression at lower concentrations. Our data
show that curcumin does not possess any antioxidant potential at
concentrations below 10 mM in any of the free radical generating
systems tested. Moreover, the impact of 1 mM curcumin on gene
expression was equally restricted. Unlike previously reported
gene array data using higher concentrations of curcumin (60), no
evidence of induction of Nrf2-responsive genes such as the
antioxidant genes, or suppression of pro-inflammatory gene sets,
was evident. This would help explain the limited impact that low
concentrations of curcumin (, 1mM) alone would have on ROS-
induced inflammation, whether or not LPS was also present.
More surprisingly, Kang and colleagues (45) have demonstrated
that curcumin can act as a HAT inhibitor at concentrations of
50mMor greater, resulting in chromatin hypoacetylation. In view
of the fact that histoneH4 hypoacetylation is associated with pro-
inflammatory gene silencing (15), some of the anti-inflammatory
properties of curcumin at such high micromolar concentrations
may also be attributed to inhibition of HAT activity. However, in
the light of such facts, it is highly unlikely that HAT inhibition by
curcumin at the concentrations used in the experiments described
here will have played any significant role. Moreover, given that
curcumin is considerablymore efficacious in restoringHDAC2 in
ROS-stressed cells at low nanomolar levels, this in turn would
help to restore the HAT/HDAC imbalance that exists under
oxidative stress (30), curtailing the magnitude of any inflamma-
tory response. Consequently, this might help to explain, in part,
why curcumin is considered to be more efficacious as an anti-
inflammatory under conditions of oxidative stress. Furthermore,
our data have implications for the treatment of conditions in
which corticosteroid resistance occurs, particularly in response to
oxidative stress by cigarette smoke.
In summary, we have shown that curcumin is able to restore
HDAC2 activity and corticosteroid efficacy in ROS-stressed
monocytes in vitro. Our data also provide further support for
the critical role HDAC2 plays in the anti-inflammatory efficacy
of corticosteroids. The molecular signaling mechanism by which
this occurs is unclear at present, but it appears likely to involve
the post-translational impact on HDAC2 by reversing protein
phosphorylation and carbonylation that ultimately prevents its
proteolytic degradation. Indeed, gene array analysis indicates
that curcumin down-regulates gene expression of proteins
involved in proteasomal degradation. Most significantly, the
concentration range at which we observed the effect of curcu-
min on restoring HDAC2 activity (EC50 z 30 nM) and
corticosteroid efficacy (EC50 z 200 nM) was at least 100-fold
lower than the effective concentration required to have any
impact on previously published in vitro targets (36, 39, 44, 45).
The identification of the molecular target propagating these
nanomolar effects of curcumin on HDAC2 would allow better
therapeutic agents, with improved bioavailability, for example,
to be developed for use in corticosteroid-resistant chronic
inflammatory diseases, such as COPD. These agents could then
be used in combination with conventional corticosteroid ther-
apies to restore HDAC2 activity and thereby improve/enhance
the anti-inflammatory efficacy of corticosteroids.
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